P
CATX
Perspective Therapeutics Inc
4.470
-0.020-0.45%After Hours: 4.465 -0.005 -0.12%18:12 04/10 EDT
OPEN/PREV CLOSE4.480/4.490
TODAY RANGE4.395-4.510
VOL498.37K
MARKET CAP509.28M
52 WEEK RANGE1.600-6.16
AVG VOL (3M)3.41M
% TURNOVER0.44%
TURNOVER--
P/E (TTM)-3.1995
% RANGE2.45%
EPS(TTM)-1.3971
P/E(FORWARD)-3.9130
P/B1.605
BVPS2.785
DIVIDEND--
P/S375.63
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP449.14M
SHARES OUTSTANDING113.93M
NEXT EARNINGS04/27-05/12
FREE FLOAT100.48M
LOT SIZE1
EX-DATE06/17/2024
News
Press Releases
Financial Reports
Profile
TipRanks·04/01 21:11
Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline
Dow Jones·03/23 11:00
Perspective Therapeutics Is Maintained at Buy by HC Wainwright & Co.
TipRanks·03/23 10:10
Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright
TipRanks·03/19 12:28
Perspective Therapeutics price target raised to $8 from $7 at UBS
Dow Jones·03/18 17:00
Perspective Therapeutics Is Maintained at Buy by B. Riley Securities
Dow Jones·03/18 13:27
Perspective Therapeutics Is Maintained at Buy by UBS
Benzinga·03/18 13:17
UBS Maintains Buy on Perspective Therapeutics, Raises Price Target to $8
TipRanks·03/18 12:51
Perspective Therapeutics price target raised to $13 from $11 at B. Riley
Dow Jones·03/18 12:49
Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush
Same Industry
Name/Symbol
Change%
Price